Vycor Medical (VYCO) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.70% |
| Dec 31, 2025 | 28.43% |
| Sep 30, 2025 | 13.97% |
| Jun 30, 2025 | 15.68% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 63.11% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 50.16% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 32.25% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 16.05% |
| Mar 31, 2023 | 24.91% |
| Dec 31, 2022 | 28.74% |
| Sep 30, 2022 | 22.01% |
| Jun 30, 2022 | 30.91% |
| Mar 31, 2022 | 19.73% |
| Dec 31, 2021 | 16.74% |
| Sep 30, 2021 | 24.21% |
| Jun 30, 2021 | 59.77% |
| Mar 31, 2021 | 30.12% |
| Sep 30, 2020 | 27.52% |
| Jun 30, 2020 | 24.21% |
| Mar 31, 2020 | 32.24% |
| Sep 30, 2019 | 39.16% |
| Jun 30, 2019 | 39.16% |
| Mar 31, 2019 | 35.56% |
| Dec 31, 2018 | 27.52% |
| Sep 30, 2018 | 34.02% |
| Jun 30, 2018 | 27.52% |
| Mar 31, 2018 | 28.89% |
| Dec 31, 2017 | 27.52% |
| Sep 30, 2017 | 26.52% |
| Jun 30, 2017 | 32.24% |
| Mar 31, 2017 | 26.52% |
| Dec 31, 2016 | 44.15% |
| Sep 30, 2016 | -93.05% |
| Jun 30, 2016 | -71.88% |
| Mar 31, 2016 | -126.79% |
| Sep 30, 2015 | -118.67% |
| Jun 30, 2015 | -109.13% |